"Designing Growth Strategies is in our DNA"

Treatment-Resistant Depression Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Type (NMDA, Antidepressants, Antipsychotics, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecasts, 2022-2029

Region : Global | Format: PDF | Report ID: FBI102820

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Treatment-Resistant Depression, By Key Countries/Regions
    2. Overview of Current Advances in R&D for Antipsychotic Drugs
    3. Pipeline Analysis of Treatment-Resistant Depression Drugs
    4. Key Industry Developments
    5. Impact of COVID-19 on Market
  5. Global Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. NMDA
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. NMDA
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. NMDA
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
  8. Asia Pacific Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. NMDA
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Treatment-Resistant Depression Treatment Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. NMDA
      2. Antidepressants
      3. Antipsychotics
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Eli Lilly and Company
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. GlaxoSmithKline
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Janssen Pharmaceuticals
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. AbbVie Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. AstraZeneca
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. H. Lundbeck
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Sandoz International GmbH
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Par Pharmaceutical Companies Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Otsuka Holdings Co., Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  Global Treatment-Resistant Depression Treatment Market Revenue Breakdown (USD billion, %) by Region, 2021 & 2029

Figure 2:  Global Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2021 & 2029

Figure 3:  Global Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2021 & 2029

Figure 4:  Global Treatment-Resistant Depression Treatment Market Value (USD billion), by Region, 2021 & 2029

Figure 5:  North America Treatment-Resistant Depression Treatment Market Value (USD billion), by Drug Type, 2021 & 2029

Figure 6:  North America Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2021

Figure 7:  North America Treatment-Resistant Depression Treatment Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 8:  North America Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2021

Figure 9:  North America Treatment-Resistant Depression Treatment Market Value (USD billion), By Country, 2021 & 2029

Figure 10:  North America Treatment-Resistant Depression Treatment Market Value Share (%), By Country, 2021

Figure 11:  Europe Treatment-Resistant Depression Treatment Market Value (USD billion), by Drug Type, 2021 & 2029

Figure 12:  Europe Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2021

Figure 13:  Europe Treatment-Resistant Depression Treatment Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 14:  Europe Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2021

Figure 15:  Europe Treatment-Resistant Depression Treatment Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 16:  Europe Treatment-Resistant Depression Treatment Market Value Share (%), By Country/ Sub-region, 2021

Figure 17:  Asia Pacific Treatment-Resistant Depression Treatment Market Value (USD billion), by Drug Type, 2021 & 2029

Figure 18:  Asia Pacific Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2021

Figure 19:  Asia Pacific Treatment-Resistant Depression Treatment Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 20:  Asia Pacific Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2021

Figure 21:  Asia Pacific Treatment-Resistant Depression Treatment Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 22:  Asia Pacific Treatment-Resistant Depression Treatment Market Value Share (%), By Country/ Sub-region, 2021

Figure 23:  Rest of the World Treatment-Resistant Depression Treatment Market Value (USD billion), by Drug Type, 2021 & 2029

Figure 24:  Rest of the World Treatment-Resistant Depression Treatment Market Value Share (%), by Drug Type, 2021

Figure 25:  Rest of the World Treatment-Resistant Depression Treatment Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 26:  Rest of the World Treatment-Resistant Depression Treatment Market Value Share (%), by Distribution Channel, 2021

Figure 27:  Global Treatment-Resistant Depression Treatment Market Share (%), By Company, 2021

Table 1:  Global Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2018-2029

Table 2:  Global Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 3:  Global Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Region, 2018-2029

Table 4:  North America Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2018-2029

Table 5:  North America Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 6:  North America Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, By Country, 2018-2029

Table 7:  Europe Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2018-2029

Table 8:  Europe Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 9:  Europe Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 10:  Asia Pacific Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2018-2029

Table 11:  Asia Pacific Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 12:  Asia Pacific Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 13:  Rest of the World Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Drug Type, 2018-2029

Table 14:  Rest of the World Treatment-Resistant Depression Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

  • Nov, 2022
  • 2021
  • 2018-2020
  • 120

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X